A European Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced (LA) or Metastatic Breast Cancer (mBC) (SAMANTHA)

NCT02913456 · clinicaltrials.gov ↗

COMPLETED

Status

629

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Sponsor

Hoffmann-La Roche